Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal

Status Suspended

Clinical Trial Summary

Study description: the study is a clinical trial aimed at assessing the validity of a point-of-care tool developed for colorectal cancer screening using urine metabolites. Objectives: Primary Objective: In the pilot phase, investigators will field test the POC device in Nigeria on 75 patients who are high-risk for CRC and then validate the urine metabolite signature using a large cohort of 645 patients at high risk for CRC and polyps. This will allow us to determine the sensitivity and specificity of this device and these signatures for CRC and polyps. Endpoints: the endpoint will be the calculation of the validity (sensitivity and specificity) of the tool. Positive and negative predictive values will also be calculated. Study population: Patients > 40 years of age with LGI bleeding for more than one-week OR - Patients who are high risk due to a family history of CRC (first-degree relative) - Must be at most 10 years younger than when relative presented with CRC (For example, a patient with a relative diagnosed at age 40 with CRC will be eligible after age 30) - Patients with a diagnosis of stage I-III CRC who have no evidence of disease Both males and females will be involved in the study I. The study will evaluate the validity and acceptability of the POC biosensor device in Nigeria. Description of sites/facilities enrolling participants: the study will be conducted at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) which hosts the head office of African Research Group for Oncology (ARGO). The study will also run concurrently at other ARGO collaborating sites. All the ARGO collaborating sites are tertiary health care facilities with experienced personnel to oversee the study. The pilot study will, however, take place in OAUTHC alone. Study duration: The accrual time for the validation study is 2.5 years. Participant Duration: the study will require initial one-time contact. Those that are positive during the screening with the POC biosensor device will be booked for colonoscopy. Hence, for participants with positive results to complete the study may require 2 weeks on average.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05679960
Study type	Interventional
Source	Obafemi Awolowo University Teaching Hospital
Contact
Status	Suspended
Phase	N/A
Start date	August 15, 2022
Completion date	March 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05929820` - Impact of Protect Your Colon™ on CRC Screening	N/A
Completed	`NCT02754661` - Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population.	N/A
Completed	`NCT00955344` - Increasing Primary Care Physician Colorectal Cancer Screening Rates	N/A
Completed	`NCT01141114` - Study of Patient Navigation to Promote Colon Cancer Screening	N/A
Completed	`NCT01250015` - Does Numerical And Pictorial Information On Risk And Benefit Affects The Uptake Of Colorectal Cancer Screening?	N/A
Completed	`NCT00503737` - Pilot Study of the National Colorectal Cancer Roundtable Toolbox (NCCRT) to Increase Colorectal Cancer Screening Rates	N/A
Completed	`NCT04746469` - Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits	N/A
Completed	`NCT03208283` - Evaluation of the Impact of Water Method During Insertion Phase of Flexible Sigmoidoscopy in Training	N/A
Not yet recruiting	`NCT03974542` - Telephone Outreach by Navigators to Improve Repeat Fecal Occult Blood Testing	N/A
Completed	`NCT03176082` - Mailed Reminders Plus Fecal Immunochemical Testing	N/A
Completed	`NCT01210235` - FLU-FIT Program at Kaiser Permanente Northern California	N/A
Completed	`NCT00793455` - Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders	N/A
Completed	`NCT01099826` - Increasing Colorectal Cancer (CRC) Screening In Primary Care	N/A
Active, not recruiting	`NCT04631692` - Evaluating a Health Literacy Intervention to Improve Colorectal Cancer Screening in Underserved Areas	N/A
Completed	`NCT03225560` - Smart Phone App for COLOnoscopic PREParation	N/A
Completed	`NCT01054924` - Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer Screening	N/A
Completed	`NCT00148226` - ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial	Phase 2
Completed	`NCT04131946` - Cancer Screening; Access; Awareness; Navigation	N/A
Recruiting	`NCT05785780` - Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings	N/A
Completed	`NCT04237883` - Primary Care Clinical Excellence Incentive Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Point of Care, Real-Time Urine Metabolomics Test to Diagnose Colorectal Cancers and Polyps in Low-and Middle-Income Countries

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms